Summit Shares Surge After-Hours on $2 Billion AstraZeneca Equity Deal

3-line summary

• Summit shares surged after-hours on a $2 billion equity deal with AstraZeneca, according to an Investing.com report.

This summary is our own processing of the source article; see the source link below for full context.